Diabetes educators may not be fully aware of the collaborative and innovative work by federal partners in guiding health care providers, as well as people with diabetes and their families, toward evidence-based decisions to optimize care.
During Sunday’s keynote address “Diabetes Safety: A Federal Focus and Partnership” at 7:30 am in Exhibit Hall A, Clydette Powell, MD, MPH, FAAP, will highlight some federal initiatives that specifically engage patients and provider groups and which draw attention to best practices in diabetes prevention and care.
Dr. Clydette Powell is the Director of the Division of Health Care Quality, Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Department of Health and Human Services. She oversees federal efforts to advance the National Action Plans for the prevention of Health Care Associated Infections and for Adverse Drug Event Prevention.
“This session seeks to address a national medical challenge and priority of the Department of Health and Human Services – adverse drug events (ADEs), and specifically, hypoglycemia due to diabetes agents,” said Dr. Powell.
She will outline the work that federal partners are doing to support the recommendations of the National Action Plan to Prevent Adverse Drug Events, with a focus on diabetes agents, including how the work is coordinated, what the various federal agencies contribute to the dialog at a health policy level, what tools have been developed for health care providers and their patients, and detail the latest developments to advance the work of federal programs in diabetes awareness and education.
“Diabetes agents are implicated in 13% of emergency department (ED) visits for ADEs; 90% of these ED visits are associated with hypoglycemia, and 39% of cases result in hospitalization. These hypoglycemic events are potentially preventable through the use of patient safety tools, individualized A1c goals, and shared decision making, thus being an important topic for all diabetes educators.”
In addition, Dr. Powell noted she will share how the FDA’s Social Media Listening Project mines Facebook and Twitter posts for personal experience with diabetes care and will introduce attendees to the National Clinical Care Commission, a federal advisory committee, whose membership includes non-federal experts in diabetes care, advocacy, research, and service delivery. She expects attendees will gain a better understanding of the federal partners and their initiatives from her talk.
“This understanding will allow diabetes educators to be better informed about the evidence-based tools that exist. In addition, we hope that diabetes educators will be interested and engaged in the upcoming federal advisory committee to help shape diabetes policies from a public health standpoint,” she said.